About Spiration
Spiration is a Healthcare company based in Redmond (United States) founded in 1999, and was acquired by Olympus America in June 2010. IntraBronchial Valve to treat lung disease. Spiration has raised $73.9 million across 6 funding rounds from investors including Boston Scientific, Credit Suisse and New Leaf Venture Partners. The company has 74 employees. The company was acqui-hired. Spiration offers products and services including Spiration Valve System. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its legal entity is Spiration, Inc. Its competitors include Pulmonx, Uptake Medical and Emphasys Medical; 3 of its 3 listed competitors have raised funding.
Company details
Spiration, develops medical devices for the treatment of air leaks and lung diseases. It developed the IBV Valve system to treat severely diseased lung in patients with heterogeneous emphysema and evidence or markers of low collateral ventilation such as complete fissures, or damaged lung resulting in air leaks, by limiting airflow to selected areas. The Spiration Valve blocks incoming breath from entering damaged portions of the lung, while it permits trapped air and mucus to escape the damaged and potentially hyper-inflated lung. It has received CE Mark regulatory approval, TGA approval in Australia, a humanitarian device exemption for treating prolonged air leaks in the United States, and CFDA approval in China and Health Canada approval for treating air leaks. As of 2010, Spiration operates as a subsidiary of Olympus America.
- Headquarters Redmond, United States
- Employees 74
- Stage Acquired
- SectorsHealthcare
- Website spiration.com
- Social LinkedIn Facebook
- Acquired by Olympus America (Jun 2010)
- Legal Name Spiration, Inc
- Total Equity Funding$73.9M (USD)
in 6 rounds
- Latest Funding Round$6.5M (USD), Debt – Conventional
Apr 2010
- InvestorsBoston Scientific
& 8 more
- Employee Count74
- Acquired byOlympus America
(Jun 2010)
Products & Services of Spiration
Spiration offers a comprehensive portfolio of products and services, including Spiration Valve System.
Minimally-invasive therapy to treat severe emphysema via valve placement
Funding Insights of Spiration
Spiration has successfully raised a total of $73.9M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $6.5 million completed in April 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $73.9M
- Total Rounds 6
- Last Round Debt – Conventional — $6.5M
- First Round $22M
(Nov 2002)
- Investors Count 9
All 6 funding rounds of Spiration with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2010 | $6.5M | Debt – Conventional | – | – | – |
| Apr 2010 | $6.5M | Series G | – | – | – |
| Sep 2009 | $7M | Debt – Conventional | – | – | – |
| Mar 2008 | $18.5M | Series G | – | Versant Ventures | |
| Jan 2004 | $26.9M | Series E | – | InterWest Partners, Investor Growth Capital | |
| Nov 2002 | $22M | Series D | – | – |
9 investors in total: 9 institutional.
Investors in Spiration
Spiration has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Credit Suisse and New Leaf Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | versantventures.com | |||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Stage-agnostic investments in US life sciences are managed. | 2005 | nlvpartners.com | New York, United States | |
Early-stage investing in IT and healthcare ventures. | interwest.com | |||
Corporate-backed venture capital firm focused on fintech, energy, and multiple sectors | investorgrowthcapital.com | New York, United States | ||
Life science & tech focused VC firm investing in companies in the US | threearchpartners.com | San Mateo, United States | ||
A wide range of medical and surgical devices is developed. | 1968 | olympusamerica.com | Center Valley, United States | |
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States | |
Wealth management, asset management, and investment banking services are offered. | 1856 | credit-suisse.com | Zurich, Switzerland |
Investor details for Spiration
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Spiration
4 dated milestones of Spiration across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Spiration is founded.
- Funding First funding round of $22.0M.
- Funding Latest funding round, Debt – Conventional, of $6.5M.
- Exit Acquired by Olympus America.
Competitors of Spiration
Spiration has 3 listed competitors in our database, 3 of them funded. They include Pulmonx, Uptake Medical and Emphasys Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pulmonx.com | 1998 | Redwood, United States | $280.91M | 198 | Developer of smart devices for treating pulmonary diseases | |
| uptakemedical.com | 2005 | Tustin, United States | $71.68M | Targeted vapor therapy is developed for endoscopic lung volume reduction. | ||
| emphasysmedical.com | 2000 | Redwood, United States | $68.4M | Endobronchial valves for emphysema treatment are developed. |
Detailed competitors of Spiration
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pulmonology
3 companies that operate in the same segment as Spiration (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Spiration
Complete news archive for Spiration
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spiration
Spiration was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Spiration is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.
Spiration is a funded company, having raised a total of $73.9M across 6 funding rounds to date. The company's 1st funding round was a Series D of $22M, raised on Nov 2002.
Spiration has 74 employees.
Spiration, develops medical devices for the treatment of air leaks and lung diseases. It developed the IBV Valve system to treat severely diseased lung in patients with heterogeneous emphysema and evidence or markers of low collateral ventilation such as complete fissures, or damaged lung resulting in air leaks, by limiting airflow to selected areas. The Spiration Valve blocks incoming breath from entering damaged portions of the lung, while it permits trapped air and mucus to escape the damaged and potentially hyper-inflated lung. It has received CE Mark regulatory approval, TGA approval in Australia, a humanitarian device exemption for treating prolonged air leaks in the United States, and CFDA approval in China and Health Canada approval for treating air leaks. As of 2010, Spiration operates as a subsidiary of Olympus America.
Spiration's top competitors include Pulmonx, Uptake Medical and Emphasys Medical.
Spiration offers Spiration Valve System.
Spiration has 9 investors. Key investors include Boston Scientific, Credit Suisse, New Leaf Venture Partners, Olympus America, and Versant Ventures.
Spiration operates through Spiration, Inc.
Yes. Spiration was acquired by Olympus America in June 2010.